These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 4393798

  • 1. Evidence for a central noradrenaline receptor stimulation by clonidine.
    Andén NE, Corrodi H, Fuxe K, Hökfelt B, Hökfelt T, Rydin C, Svensson T.
    Life Sci; 1970 May 01; 9(9):513-23. PubMed ID: 4393798
    [No Abstract] [Full Text] [Related]

  • 2. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.
    Andén NE, Grabowska M, Strömbom U.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 May 01; 292(1):43-52. PubMed ID: 6918
    [Abstract] [Full Text] [Related]

  • 3. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
    Andén NE, Strömbom U.
    Psychopharmacologia; 1974 May 01; 38(2):91-103. PubMed ID: 4533319
    [No Abstract] [Full Text] [Related]

  • 4. FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline.
    Andén NE, Grabowska M.
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jul 01; 298(3):239-43. PubMed ID: 19710
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain.
    Andén N, Grabowska M.
    Eur J Pharmacol; 1976 Oct 01; 39(2):275-82. PubMed ID: 185062
    [Abstract] [Full Text] [Related]

  • 6. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE, Engel J.
    Adv Neurol; 1974 Oct 01; 5():317-24. PubMed ID: 4613158
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Noradrenaline synthesis and utilization: control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents.
    Grabowska M, Andén NE.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct 01; 292(1):53-8. PubMed ID: 6919
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of 4-aminopyridine on the turnover of monoamines in the central nervous system of the rat.
    Andén NE, Leander S.
    J Neural Transm; 1979 Oct 01; 44(1-2):1-12. PubMed ID: 438799
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence of adrenergic--cholinergic interaction in the central nervous system. II. Dopamine and its analogues.
    Ho AK, Lo HH.
    Eur J Pharmacol; 1972 Aug 01; 19(2):145-50. PubMed ID: 4341974
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased impulse flow in bulbospinal noradrenaline neurons produced by catecholamine receptor blocking agents.
    Andén NE, Corrodi H, Fuxe K, Hökfelt T.
    Eur J Pharmacol; 1967 Oct 01; 2(1):59-64. PubMed ID: 5585238
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems.
    McMillen BA, Shore PA.
    J Pharm Pharmacol; 1978 Jul 01; 30(7):464-6. PubMed ID: 27622
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.